CD8 詳細
Molecule Name
Cluster of differentiation 8
分子の別称
CD8
Drug Development Progress
治験薬の数18
市販薬剤の数0
研究＆開発段階Phase 3 Clinical
ターゲットの別称
CD8 Antigens
CD8 製品リスト
You Have Viewed 0 Of 0 Results
治験薬に関する情報
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| 89Zr-Df-crefmirlimab | IAB-22-M2C | Phase 3 Clinical | Imaginab Inc | Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Melanoma; Multiple Sclerosis; Skin Melanoma; Solid tumours | 詳細 |
| RB-0003 | RB-0003; BNT-111 | Phase 2 Clinical | Biontech Se, Tron | Melanoma | 詳細 |
| CD8+ memory T cell therapy (Stanford University) | Phase 2 Clinical | Stanford University | Leukemia; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| GEN-009 | GEN-009 | Phase 2 Clinical | Genocea Biosciences Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| VE-800 | VE-800 | Phase 2 Clinical | Vedanta Biosciences Inc | Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Neoplasm Metastasis; Stomach Neoplasms | 詳細 |
| EBViNT Cell (Eutilex) | Phase 2 Clinical | Eutilex | Lymphoma, Extranodal NK-T-Cell | 詳細 | |
| ZED88082A | ZED88082A | Phase 2 Clinical | Umcg The University Medical Center Groningen | Neoplasm Metastasis; Neoplasms | 詳細 |
| AZD-6750 | AZD6750; AZD-6750 | Phase 2 Clinical | Astrazeneca Plc | Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Melanoma; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| AZD-9793 | AZD9793; AZD-9793 | Phase 2 Clinical | Astrazeneca Plc | Carcinoma, Hepatocellular; Neoplasm Metastasis; Solid tumours | 詳細 |
| AZD-5492 | AZD5492 | Phase 2 Clinical | Astrazeneca Plc | Arthritis, Rheumatoid; Leukemia, B-Cell; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Myositis; Neoplasms | 詳細 |
| SNA-006 | 68-Ga-NODAGA-SNA-006; 68Ga-NODAGA-SNA006; SNA-006 | Phase 2 Clinical | Smartnuclide Biopharma | Neoplasms; Solid tumours | 詳細 |
| NY-ESO-1-specific autologous CD8+ T-cell therapy (Fred Hutchinson Cancer Research Center) | Phase 1 Clinical | Fred Hutchinson Cancer Research Center, National Cancer Institute | Liposarcoma; Sarcoma; Sarcoma, Synovial | 詳細 | |
| MTX-101 (Mozart Therapeutics) | MTX-101 (Mozart Therapeutics) | Phase 1 Clinical | Mozart Therapeutics Inc | Autoimmune Diseases; Diabetes Mellitus, Type 1 | 詳細 |
| [18F]GEH200521 | GEH200521 (18F); GEH-200521 | Phase 1 Clinical | Ge Healthcare | Solid tumours | 詳細 |
| Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) | Phase 1 Clinical | Second Affiliated Hospital School Of Zhejiang University School Of Medicine | Gastroesophageal Junction Neoplasms; Stomach Neoplasms | 詳細 | |
| SCRI-E2CAR_EGFRtv1 | SCRI-E2CAR_EGFRtv1 | Phase 1 Clinical | Umoja BioPharma Inc | Osteosarcoma | 詳細 |
| 89Zr-DFO-REGN5054 | 89Zr-DFO-REGN5054 | Phase 1 Clinical | Regeneron Pharmaceuticals Inc | Solid tumours | 詳細 |
| AGX-148 | AGX-148; AGX148 | Phase 1 Clinical | AgonOx Inc | Colorectal Neoplasms; Genital Neoplasms, Female; Lung Neoplasms; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Urogenital Neoplasms | 詳細 |